$KPTI Cashflow Statement | Understand Stock

$KPTI

$0.44 -$0.04 (8.82%) Live

$KPTI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense
Realized and unrealized gains on marketable equity securities
Depreciation and amortization
Amortization of debt issuance costs and discounts
Interest expense added to debt principal
Net amortization of premiums and discounts on investments
Acquired in-process research and development
Other
Loss (gain) on extinguishment of debt
Change in fair value of embedded derivatives and common stock warrants

Changes in operating assets and liabilities:
Accounts receivable, net
Inventory
Prepaid expenses and other assets
Operating lease right-of-use assets
Other assets
Accounts payable
Accrued expenses and other liabilities
Deferred revenue
Operating lease liabilities

Net cash used in operating activities
Investing activities
Proceeds from maturities of investments
Purchases of investments
Purchases of property and equipment
Acquired in-process research and development
Net cash provided by investing activities
Financing activities
Proceeds from convertible debt
Proceeds from senior secured term loan
Proceeds from issuance of common stock and warrants in private placement offering
Proceeds from the exercise of stock options and shares issued under the employee stock purchase plan
Proceeds from Amended Revenue Interest Agreement
Payment of debt issuance costs
Payment of convertible debt
Payment of deferred royalty obligation
Payment of debt and equity issuance costs
Net cash provided by financing activities
Effect of exchange rates on cash, cash equivalents and restricted cash
Net (decrease) increase in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of period
Cash, cash equivalents and restricted cash at end of period
Supplemental disclosures:
Cash paid for interest on convertible debt
Cash paid for interest on deferred royalty obligation
Cash paid for interest on convertible debt and term loan
Cash paid for amounts included in the measurement of operating lease liabilities
Lease liabilities arising from obtaining right-of-use assets
Common stock and warrants issued in exchange for reduction of convertible senior notes
Convertible senior notes due 2025
Convertible senior notes due 2029
Debt issued for interest payments
Convertible senior notes due 2029 issued with warrants to purchase 3,100 shares of common stock in exchange for a $148,000 reduction of convertible senior notes due 2025
Senior secured term loan issued in exchange for a $14,700 reduction of deferred royalty obligation
Issuance of common stock and warrants used to settle fees related to financing activities
Convertible senior notes due 2029 issued in exchange for a $5,000 reduction of deferred royalty obligation

Reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets
Cash and cash equivalents
Short-term restricted cash
Long-term restricted cash

Comments